Premarket Decliner
ACTU Actuate Therapeutics8.51+0.57+7.2%
Premarket:6.79-1.72 (-20.2%)
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
Globe NewswireWed, 10-Sep 8:31 AM